Extension Study Following the Studies MT-1186-A03 or A04 to Evaluate the Safety of Oral Edaravone in Subjects With ALS
Clinical trial NCT05568615 · COMPLETED
Trial details
- NCT number
- NCT05568615
- Sponsor
- Shionogi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-26
- Primary completion
- 2023-06-27
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.